Eric Bjerkholt - Net Worth and Insider Trading

Eric Bjerkholt Net Worth

The estimated net worth of Eric Bjerkholt is at least $4 Million dollars as of 2024-04-27. Eric Bjerkholt is the CFO of Chinook Therapeutics Inc and owns about 38,867 shares of Chinook Therapeutics Inc (KDNY) stock worth over $2 Million. Eric Bjerkholt is the CFO of Aimmune Therapeutics Inc and owns about 42,967 shares of Aimmune Therapeutics Inc (AIMT) stock worth over $1 Million. Eric Bjerkholt is also the CHIEF FINANCIAL OFFICER of Mirum Pharmaceuticals Inc and owns about 14,000 shares of Mirum Pharmaceuticals Inc (MIRM) stock worth over $342,440. Besides these, Eric Bjerkholt also holds Corium International Inc (CORI) , Cerus Corp (CERS) , CalciMedica Inc (CALC) , Sunesis Pharmaceuticals Inc (SNSS) . Details can be seen in Eric Bjerkholt's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Eric Bjerkholt has not made any transactions after 2024-03-27 and currently still holds the listed stock(s).

Transaction Summary of Eric Bjerkholt

To

Eric Bjerkholt Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Eric Bjerkholt owns 10 companies in total, including Aimmune Therapeutics Inc (AIMT) , Cerus Corp (CERS) , and CalciMedica Inc (CALC) among others .

Click here to see the complete history of Eric Bjerkholt’s form 4 insider trades.

Insider Ownership Summary of Eric Bjerkholt

Ticker Comapny Transaction Date Type of Owner
AIMT Aimmune Therapeutics Inc 2020-10-10 Chief Financial Officer
CERS Cerus Corp 2023-12-13 director
CALC CalciMedica Inc 2023-05-31 director
CORI Corium International Inc 2018-11-27 director
SNSS Sunesis Pharmaceuticals Inc 2016-11-30 EVP & CFO & Corp. Secretary
MBOT Microbot Medical Inc 2004-03-01 director
VIRX Viracta Therapeutics Inc 2005-09-27 Senior VP & CFO
KDNY Chinook Therapeutics Inc 2023-02-10 Chief Financial Officer
SRZN Surrozen Inc 2023-04-05 director
MIRM Mirum Pharmaceuticals Inc 2024-03-27 Chief Financial Officer

Eric Bjerkholt Latest Holdings Summary

Eric Bjerkholt currently owns a total of 7 stocks. Among these stocks, Eric Bjerkholt owns 38,867 shares of Chinook Therapeutics Inc (KDNY) as of February 10, 2023, with a value of $2 Million and a weighting of 39.53%. Eric Bjerkholt owns 42,967 shares of Aimmune Therapeutics Inc (AIMT) as of March 12, 2020, with a value of $1 Million and a weighting of 37.32%. Eric Bjerkholt also owns 14,000 shares of Mirum Pharmaceuticals Inc (MIRM) as of March 27, 2024, with a value of $342,440 and a weighting of 8.62%. The other 4 stocks Corium International Inc (CORI) , Cerus Corp (CERS) , CalciMedica Inc (CALC) , Sunesis Pharmaceuticals Inc (SNSS) have a combined weighting of 14.53% among all his current holdings.

Latest Holdings of Eric Bjerkholt

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
KDNY Chinook Therapeutics Inc 2023-02-10 38,867 40.39 1,569,838
AIMT Aimmune Therapeutics Inc 2020-03-12 42,967 34.49 1,481,932
MIRM Mirum Pharmaceuticals Inc 2024-03-27 14,000 24.46 342,440
CORI Corium International Inc 2016-05-19 24,500 12.68 310,660
CERS Cerus Corp 2023-12-13 142,133 1.71 243,047
CALC CalciMedica Inc 2023-05-31 3,684 5.45 20,078
SNSS Sunesis Pharmaceuticals Inc 2015-07-24 637 5.32 3,389

Holding Weightings of Eric Bjerkholt


Eric Bjerkholt Form 4 Trading Tracker

According to the SEC Form 4 filings, Eric Bjerkholt has made a total of 4 transactions in Chinook Therapeutics Inc (KDNY) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Chinook Therapeutics Inc is the sale of 857 shares on February 10, 2023, which brought Eric Bjerkholt around $20,354.

According to the SEC Form 4 filings, Eric Bjerkholt has made a total of 3 transactions in Aimmune Therapeutics Inc (AIMT) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Aimmune Therapeutics Inc is the acquisition of 1,000 shares on March 12, 2020, which cost Eric Bjerkholt around $15,100.

According to the SEC Form 4 filings, Eric Bjerkholt has made a total of 3 transactions in Mirum Pharmaceuticals Inc (MIRM) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Mirum Pharmaceuticals Inc is the acquisition of 2,000 shares on March 27, 2024, which cost Eric Bjerkholt around $49,600.

More details on Eric Bjerkholt's insider transactions can be found in the Insider Trading History of Eric Bjerkholt table.

Insider Trading History of Eric Bjerkholt

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Eric Bjerkholt Trading Performance

GuruFocus tracks the stock performance after each of Eric Bjerkholt's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Eric Bjerkholt is 10.88%. GuruFocus also compares Eric Bjerkholt's trading performance to market benchmark return within the same time period. The performance of stocks bought by Eric Bjerkholt within 3 months outperforms 9 times out of 16 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Eric Bjerkholt's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Eric Bjerkholt

Average Return

31.84%

Average return per transaction

Outperforming Transactions

67%

4 out of 6 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 9.68 10.88 24.32 31.84 7.61 -6.82
Relative Return to S&P 500(%) 8.6 5.07 16.06 21.95 -2.81 -13.72

Eric Bjerkholt Ownership Network

Ownership Network List of Eric Bjerkholt

No Data

Ownership Network Relation of Eric Bjerkholt


Eric Bjerkholt Owned Company Details

What does Aimmune Therapeutics Inc do?

Who are the key executives at Aimmune Therapeutics Inc?

Eric Bjerkholt is the Chief Financial Officer of Aimmune Therapeutics Inc. Other key executives at Aimmune Therapeutics Inc include 10 percent owner Societe Des Produits Nestle S.a. , Chief Medical Officer Adelman Daniel C Md , and See Remarks Douglas T. Sheehy .

Aimmune Therapeutics Inc (AIMT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aimmune Therapeutics Inc (AIMT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aimmune Therapeutics Inc (AIMT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aimmune Therapeutics Inc (AIMT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Aimmune Therapeutics Inc Insider Transactions

No Available Data

Eric Bjerkholt Mailing Address

Above is the net worth, insider trading, and ownership report for Eric Bjerkholt. You might contact Eric Bjerkholt via mailing address: 132 Purdure Avenue, Kengsington Ca 94708.

Discussions on Eric Bjerkholt

No discussions yet.